This inventor holds 3 USPTO granted patents. Top assignee: Glaxo Group Limited. Active years: 2009-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2013
Title: Kishore Kalidas Rana: Innovator in Pharmacological Research
Introduction
Kishore Kalidas Rana is a notable inventor based in Harlow, GB. He has made significant contributions to the field of pharmacology, particularly through his innovative work on diazepine derivatives. With a total of 3 patents, his research focuses on developing compounds that have the potential to treat neurological and psychiatric disorders.
Latest Patents
Among his latest patents, Kishore has developed 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists. This invention relates to novel diazepanyl derivatives that exhibit pharmacological activity. The processes for their preparation, compositions containing them, and their applications in treating various disorders are also covered in his patents.
Career Highlights
Kishore Kalidas Rana is currently associated with Glaxo Group Limited, where he continues to advance his research in pharmacology. His work has garnered attention for its potential impact on therapeutic approaches to complex health issues.
Collaborations
Kishore has collaborated with esteemed colleagues such as Gordon Bruton and Barry S Orlek, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Kishore Kalidas Rana's contributions to pharmacological research through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to pave the way for advancements in the treatment of neurological and psychiatric disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile